FIELD: medicine.
SUBSTANCE: for post-traumatic stress disorder treatment, an effective amount of vasopressin antagonist of formula
or
or 
is introduced.
EFFECT: method provides effective correction of PTSD due to the selective action of these compounds on vasopressin receptors in the brain.
11 cl, 238 ex, 2 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATMENT OF POST-TRAUMATIC STRESS DISORDER | 2011 |
|
RU2775783C2 |
| COMPOSITIONS AND METHODS OF TREATING NEURODEGENERATIVE DISEASES | 2015 |
|
RU2742773C2 |
| COMPOSITIONS AND METHODS FOR TREATMENT OF BRAIN DAMAGE | 2018 |
|
RU2797548C2 |
| PYRROLOPYRAZINE KINASE INHIBITORS | 2012 |
|
RU2673064C2 |
| METHODS FOR PREPARING DERIVATIVES OF 1-[2-(BENZIMIDAZOL-1-YL)QUINOLIN-8-YL]PIPERIDIN-4-YLAMINE | 2004 |
|
RU2323214C2 |
| ISOXAZOLINES AND ISOXAZOLES, METHOD OF INHIBITION OF PLATELET AGGREGATION, PHARMACEUTICAL COMPOSITION INHIBITING PLATELET AGGREGATION | 1994 |
|
RU2149871C1 |
| 5-AMINOCYCLYLMETHYLOXAZOLIDIN-2-ONE DERIVATIVES | 2008 |
|
RU2492169C2 |
| SUBSTITUTED 2,6-DIOXOPIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS OF DECREASE OF TUMOR NECROSIS FACTOR-α LEVEL | 1997 |
|
RU2595250C1 |
| SUBSTITUTED 2,6-DIOXOPIPERIDINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHOD OF DECREASE OF TUMOR NECROSIS FACTOR- LEVEL | 1997 |
|
RU2177944C2 |
| OXAZOLIDINE ANTIBIOTICS | 2009 |
|
RU2516701C2 |
